Global Biosimilar Monoclonal Antibodies Sales Market Report 2017

世界のバイオシミラーモノクローナル抗体市場:販売動向2017

◆タイトル:Global Biosimilar Monoclonal Antibodies Sales Market Report 2017
◆商品コード:QYR70326642
◆調査・発行会社:QYResearch
◆発行日:2017年2月22日
◆ページ数:105
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、バイオシミラーモノクローナル抗体の世界市場について調査・分析し、バイオシミラーモノクローナル抗体のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、バイオシミラーモノクローナル抗体産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・バイオシミラーモノクローナル抗体市場概要
・バイオシミラーモノクローナル抗体のメーカー別販売量・メーカー別シェア
・バイオシミラーモノクローナル抗体の世界市場:種類別販売量・市場シェア
・バイオシミラーモノクローナル抗体の世界市場:用途別販売量・市場シェア
・バイオシミラーモノクローナル抗体の世界市場:地域別販売量・市場シェア
・バイオシミラーモノクローナル抗体のアメリカ市場規模
・バイオシミラーモノクローナル抗体の中国市場規模
・バイオシミラーモノクローナル抗体のヨーロッパ市場規模
・バイオシミラーモノクローナル抗体の日本市場規模
・バイオシミラーモノクローナル抗体の東南アジア市場規模
・バイオシミラーモノクローナル抗体のインド市場規模
・バイオシミラーモノクローナル抗体のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・バイオシミラーモノクローナル抗体のコスト分析・価格動向
・バイオシミラーモノクローナル抗体の産業チェーン(サプライチェーン分析)
・バイオシミラーモノクローナル抗体のマーケティング戦略・販売チャネル、流通業者
・バイオシミラーモノクローナル抗体市場への影響要因分析
・バイオシミラーモノクローナル抗体の世界市場予測
・バイオシミラーモノクローナル抗体のアメリカ市場予測
・バイオシミラーモノクローナル抗体の中国市場予測
・バイオシミラーモノクローナル抗体のヨーロッパ市場予測
・バイオシミラーモノクローナル抗体の日本市場予測
・バイオシミラーモノクローナル抗体の東南アジア市場予測
・バイオシミラーモノクローナル抗体のインド市場予測
・バイオシミラーモノクローナル抗体の種類別世界市場予測
・バイオシミラーモノクローナル抗体の用途別世界市場予測
...

Notes:Sales, means the sales volume of Biosimilar Monoclonal Antibodies
Revenue, means the sales value of Biosimilar Monoclonal Antibodies

This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Celltrion
Boehringer Ingelheim
Dr Reddy’s
Sandoz
Zydus
Samsung
Amgen
Hospira
Shanghai CP Guojian Pharmaceutical

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biosimilar Monoclonal Antibodies in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Monoclonal Antibodies in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Biosimilar Monoclonal Antibodies Sales Market Report 2017
1 Biosimilar Monoclonal Antibodies Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Classification of Biosimilar Monoclonal Antibodies
1.2.1 Type I
1.2.2 Type II
1.3 Application of Biosimilar Monoclonal Antibodies
1.3.1 Application 1
1.3.2 Application 2
1.4 Biosimilar Monoclonal Antibodies Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biosimilar Monoclonal Antibodies (2012-2022)
1.5.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2022)
1.5.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)

2 Global Biosimilar Monoclonal Antibodies Competition by Manufacturers, Type and Application
2.1 Global Biosimilar Monoclonal Antibodies Market Competition by Manufacturers
2.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Share by Manufacturers (2012-2017)
2.2 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Type
2.2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2012-2017)
2.2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
2.3 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Regions
2.3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2012-2017)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2012-2017)
2.4 Global Biosimilar Monoclonal Antibodies (Volume) by Application

3 United States Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
3.1 United States Biosimilar Monoclonal Antibodies Sales and Value (2012-2017)
3.1.1 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
3.1.2 United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
3.1.3 United States Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
3.2 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
3.3 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Type
3.4 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Application

4 China Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
4.1 China Biosimilar Monoclonal Antibodies Sales and Value (2012-2017)
4.1.1 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
4.1.2 China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
4.1.3 China Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
4.2 China Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
4.3 China Biosimilar Monoclonal Antibodies Sales and Market Share by Type
4.4 China Biosimilar Monoclonal Antibodies Sales and Market Share by Application

5 Europe Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
5.1 Europe Biosimilar Monoclonal Antibodies Sales and Value (2012-2017)
5.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
5.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
5.1.3 Europe Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
5.2 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
5.3 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type
5.4 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Application

6 Japan Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
6.1 Japan Biosimilar Monoclonal Antibodies Sales and Value (2012-2017)
6.1.1 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
6.1.2 Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
6.1.3 Japan Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
6.2 Japan Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
6.3 Japan Biosimilar Monoclonal Antibodies Sales and Market Share by Type
6.4 Japan Biosimilar Monoclonal Antibodies Sales and Market Share by Application
7 Southeast Asia Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
7.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Value (2012-2017)
7.1.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
7.2 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
7.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Market Share by Type
7.4 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Market Share by Application
8 India Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
8.1 India Biosimilar Monoclonal Antibodies Sales and Value (2012-2017)
8.1.1 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
8.1.2 India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
8.1.3 India Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
8.2 India Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
8.3 India Biosimilar Monoclonal Antibodies Sales and Market Share by Type
8.4 India Biosimilar Monoclonal Antibodies Sales and Market Share by Application

9 Global Biosimilar Monoclonal Antibodies Manufacturers Analysis
9.1 Celltrion
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Boehringer Ingelheim
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Dr Reddy’s
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Sandoz
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Zydus
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Samsung
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Amgen
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Hospira
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Shanghai CP Guojian Pharmaceutical
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview

10 Biosimilar Monoclonal Antibodies Maufacturing Cost Analysis
10.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
10.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Biosimilar Monoclonal Antibodies Market Forecast (2017-2022)
14.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2017-2022)
14.2 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Biosimilar Monoclonal Antibodies
Table Classification of Biosimilar Monoclonal Antibodies
Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Biosimilar Monoclonal Antibodies
Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Table Global Biosimilar Monoclonal Antibodies Sales of Key Manufacturers (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2012-2017)
Figure 2015 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Figure 2016 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Table Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2012-2017)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2012-2017)
Figure Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Type (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Regions (2012-2017)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Regions (2012-2017)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Regions (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions (2012-2017)
Figure Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Regions (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2012-2017)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2012-2017)
Figure Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2012-2017)
Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure United States Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
Table United States Biosimilar Monoclonal Antibodies Sales by Manufacturers (2012-2017)
Table United States Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2012-2017)
Table United States Biosimilar Monoclonal Antibodies Sales by Type (2012-2017)
Table United States Biosimilar Monoclonal Antibodies Market Share by Type (2012-2017)
Table United States Biosimilar Monoclonal Antibodies Sales by Application (2012-2017)
Table United States Biosimilar Monoclonal Antibodies Market Share by Application (2012-2017)
Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure China Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
Table China Biosimilar Monoclonal Antibodies Sales by Manufacturers (2012-2017)
Table China Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2012-2017)
Table China Biosimilar Monoclonal Antibodies Sales by Type (2012-2017)
Table China Biosimilar Monoclonal Antibodies Market Share by Type (2012-2017)
Table China Biosimilar Monoclonal Antibodies Sales by Application (2012-2017)
Table China Biosimilar Monoclonal Antibodies Market Share by Application (2012-2017)
Figure Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Europe Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Europe Biosimilar Monoclonal Antibodies Sales by Manufacturers (2012-2017)
Table Europe Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2012-2017)
Table Europe Biosimilar Monoclonal Antibodies Sales by Type (2012-2017)
Table Europe Biosimilar Monoclonal Antibodies Market Share by Type (2012-2017)
Table Europe Biosimilar Monoclonal Antibodies Sales by Application (2012-2017)
Table Europe Biosimilar Monoclonal Antibodies Market Share by Application (2012-2017)
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Japan Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Japan Biosimilar Monoclonal Antibodies Sales by Manufacturers (2012-2017)
Table Japan Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2012-2017)
Table Japan Biosimilar Monoclonal Antibodies Sales by Type (2012-2017)
Table Japan Biosimilar Monoclonal Antibodies Market Share by Type (2012-2017)
Table Japan Biosimilar Monoclonal Antibodies Sales by Application (2012-2017)
Table Japan Biosimilar Monoclonal Antibodies Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Southeast Asia Biosimilar Monoclonal Antibodies Sales by Manufacturers (2012-2017)
Table Southeast Asia Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2012-2017)
Table Southeast Asia Biosimilar Monoclonal Antibodies Sales by Type (2012-2017)
Table Southeast Asia Biosimilar Monoclonal Antibodies Market Share by Type (2012-2017)
Table Southeast Asia Biosimilar Monoclonal Antibodies Sales by Application (2012-2017)
Table Southeast Asia Biosimilar Monoclonal Antibodies Market Share by Application (2012-2017)
Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure India Biosimilar Monoclonal Antibodies Sales Price Trend (2012-2017)
Table India Biosimilar Monoclonal Antibodies Sales by Manufacturers (2012-2017)
Table India Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2012-2017)
Table India Biosimilar Monoclonal Antibodies Sales by Type (2012-2017)
Table India Biosimilar Monoclonal Antibodies Market Share by Type (2012-2017)
Table India Biosimilar Monoclonal Antibodies Sales by Application (2012-2017)
Table India Biosimilar Monoclonal Antibodies Market Share by Application (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celltrion Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Dr Reddy’s Basic Information List
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dr Reddy’s Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sandoz Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Zydus Basic Information List
Table Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Zydus Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Samsung Basic Information List
Table Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Samsung Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hospira Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Shanghai CP Guojian Pharmaceutical Basic Information List
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Biosimilar Monoclonal Antibodies
Table Distributors/Traders List
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のバイオシミラーモノクローナル抗体市場:販売動向2017] (Global Biosimilar Monoclonal Antibodies Sales Market Report 2017 / QYR70326642)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆